Ansell Applauded by Frost & Sullivan for Protecting Clinicians and Patients Using Latex-free Gloves, and Its Market-leading Position
Ansell's solutions combine an ergonomic design and skin-friendly technology to shield surgeons' and clinicians' hands, their most valuable asset in delivering care, and supporting their overall quality of life. SAN ANTONIO, Feb. 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the medical gloves industry, and, based on its assessment results, recognizes Ansell...
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax’ COVID-19 Vaccine
Modified agreement also includes the development of an updated vaccine in fall 2023 GAITHERSBURG, Md., Feb. 13, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a modification to its existing agreement with the U.S....
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for Treatment of Relapsed/Refractory Multiple Myeloma
Approval follows U.S. FDA clearance of IND application for BCMA/CD19 dual-targeting FasTCAR-T GC012F Company plans to initiate Phase 1/2 clinical trial in China in third quarter of 2023 SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Feb. 13, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a...
Vmade Launched Cooperation with Fulgent Life to Build a Cross-Border SaaS and Payment Integration Solution for Private Growth
BEIJING, Feb. 13, 2023 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider committed to providing technical support and digital transformation tools for enterprises across multiple industries, today announced that its strategic partner Vmade Tech PTE. LTD ("Vmade") has launched cooperation with Fulgent Life INC( "Fulgent Life"). Vmade will build...
Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company’s Novel Adjuvanted Recombinant Shingles Vaccine REC610
TAIZHOU, China, Feb. 13, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the Group has recently completed the first batch of subject enrollment for its novel adjuvanted recombinant shingles vaccine, REC610. The study is a randomized, observer-blinded, GSK Shingrix®...
Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease
TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ -- Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. Magic Touch PTA has received US FDA IDE approval for its BTK indication The Magic Touch PTA Sirolimus...
B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand
- Responding to Growing Needs for Urban-type Proton Therapy in Thailand - TOKYO and BANGKOK, Feb. 13, 2023 /PRNewswire/ -- B dot Medical Inc. and Thammasat University, a leading national university in Thailand, have signed a memorandum of understanding to install the ultra-compact proton therapy system developed by B dot Medical. The agreement encourages installing the advanced cancer treatment system in Thailand, where the...
Boan Biotech’s Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
YANTAI, China, Feb. 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that BA1106, an investigational non-IL-2 blocking anti-CD25 antibody developed by its subsidiary Boan Biotech, has been administered for the first patient in a Phase I clinical trial. This trial is designed to evaluate the safety, pharmacokinetics and preliminary efficacy of BA1106 in patients with advanced solid tumors....
NCSM & DoctorOnCall Join Forces to Promote Free COVID-19 Vaccination and Booster Doses (Including On-site and House-to-House)
KUALA LUMPUR, Malaysia, Feb. 13, 2023 /PRNewswire/ -- The National Cancer Society Malaysia (NCSM) and DoctorOnCall are proud to announce their continued collaboration in raising awareness on the importance and accessibility of COVID-19 vaccination including booster shots. As trusted healthcare partners, NCSM and DoctorOnCall have been working together since December 2020 to improve the accessibility and affordability of medical services...
VISTA Eye Specialist to Showcase Latest Eye Care Technology
PETALING JAYA, Malaysia, Feb. 13, 2023 /PRNewswire/ -- In collaboration with Ziemer Ophthalmic Systems AG (Ziemer), one of the leading Ophthalmic companies based in Switzerland, VISTA Eye Specialist (VISTA) will be hosting surgeons from around the world on 22nd February, to participate in a variety of activities featuring the Ziemer LDV Z8 Femtosecond Laser Platform - one of the most...
